Tumor size (OR 0.34, 95% CI 0.04–2.77, p = 0.313), ETE (OR 2.162, 95% CI 0.57–8.16, p = 0.255), and BRAF mutation (OR 0.322, 95% CI 0.06–1.89, p = 0.21) were not significantly associated with HRLNM. The gene discussed is BRAF; the disease is neoplasm.